-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
-
Summary
-
Catalyst Pharmaceuticals, Inc. quarterly/annual Amortization of Intangible Assets history and change rate from 2021 to Q1 2025.
- Catalyst Pharmaceuticals, Inc. Amortization of Intangible Assets for the quarter ending March 31, 2025 was $9.35M, a 0.01% increase year-over-year.
- Catalyst Pharmaceuticals, Inc. annual Amortization of Intangible Assets for 2024 was $37.4M, a 14.8% increase from 2023.
- Catalyst Pharmaceuticals, Inc. annual Amortization of Intangible Assets for 2023 was $32.6M, a 2866% increase from 2022.
- Catalyst Pharmaceuticals, Inc. annual Amortization of Intangible Assets for 2022 was $1.1M.
Amortization of Intangible Assets, Quarterly (USD)
Amortization of Intangible Assets, YoY Quarterly Change (%)
Amortization of Intangible Assets, Annual (USD)
Amortization of Intangible Assets, YoY Annual Change (%)